These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18621715)

  • 1. A Cre-loxP-based mouse model for conditional somatic gene expression and knockdown in vivo by using avian retroviral vectors.
    Seidler B; Schmidt A; Mayr U; Nakhai H; Schmid RM; Schneider G; Saur D
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10137-42. PubMed ID: 18621715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of avian retroviruses and tissue-specific somatic retroviral gene transfer in vivo using the RCAS/TVA system.
    von Werder A; Seidler B; Schmid RM; Schneider G; Saur D
    Nat Protoc; 2012 May; 7(6):1167-83. PubMed ID: 22635109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of avian retroviral vectors to introduce transcriptional regulators into mammalian cells for analyses of tumor maintenance.
    Pao W; Klimstra DS; Fisher GH; Varmus HE
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8764-9. PubMed ID: 12857957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
    Lewis BC; Klimstra DS; Varmus HE
    Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific induced DNA methyltransferase 1 (Dnmt1) in endocrine pancreas by RCAS-TVA-based somatic gene transfer system promotes β-cell proliferation.
    Yuan Z; Gardiner JC; Maggi EC; Adem A; Zhang G; Lee S; Romanienko P; Du YN; Libutti SK
    Cancer Gene Ther; 2019 Mar; 26(3-4):94-102. PubMed ID: 30190513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel Flk1-TVA transgenic mouse model for gene delivery to angiogenic vasculature.
    Vervoort VS; Lu M; Valencia F; Lesperance J; Breier G; Oshima R; Pasquale EB
    Transgenic Res; 2008 Jun; 17(3):403-15. PubMed ID: 18027100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models.
    Du Z; Podsypanina K; Huang S; McGrath A; Toneff MJ; Bogoslovskaia E; Zhang X; Moraes RC; Fluck M; Allred DC; Lewis MT; Varmus HE; Li Y
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17396-401. PubMed ID: 17090666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RCAS-mediated retroviral gene delivery: a versatile tool for the study of gene function in a mouse model of pancreatic cancer.
    Mayr U; von Werder A; Seidler B; Reindl W; Bajbouj M; Schmid RM; Schneider G; Saur D
    Hum Gene Ther; 2008 Sep; 19(9):896-906. PubMed ID: 18759559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the RCAS-TVA system to model human cancer in mice.
    Ahronian LG; Lewis BC
    Cold Spring Harb Protoc; 2014 Nov; 2014(11):1128-35. PubMed ID: 25368315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vivo model to study osteogenic gene regulation: targeting an avian retroviral receptor (TVA) to bone with the bone sialoprotein (BSP) promoter.
    Li L; Zhu J; Tu Q; Yamauchi M; Sodek J; Karsenty G; Tang J; Chen J
    J Bone Miner Res; 2005 Aug; 20(8):1403-13. PubMed ID: 16007338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble forms of the subgroup A avian leukosis virus [ALV(A)] receptor Tva significantly inhibit ALV(A) infection in vitro and in vivo.
    Holmen SL; Salter DW; Payne WS; Dodgson JB; Hughes SH; Federspiel MJ
    J Virol; 1999 Dec; 73(12):10051-60. PubMed ID: 10559319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a flexible and specific gene delivery system for production of murine tumor models.
    Fisher GH; Orsulic S; Holland E; Hively WP; Li Y; Lewis BC; Williams BO; Varmus HE
    Oncogene; 1999 Sep; 18(38):5253-60. PubMed ID: 10498877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intronic deletions of tva receptor gene decrease the susceptibility to infection by avian sarcoma and leukosis virus subgroup A.
    Chen W; Liu Y; Li H; Chang S; Shu D; Zhang H; Chen F; Xie Q
    Sci Rep; 2015 Apr; 5():9900. PubMed ID: 25873518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional expression of the TVA receptor allows clonal analysis of descendents from Cre-expressing progenitor cells.
    Beier KT; Samson ME; Matsuda T; Cepko CL
    Dev Biol; 2011 May; 353(2):309-20. PubMed ID: 21397594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An RCAS-TVA-based approach to designer mouse models.
    Orsulic S
    Mamm Genome; 2002 Oct; 13(10):543-7. PubMed ID: 12420130
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
    Fendrich V; Jendryschek F; Beeck S; Albers M; Lauth M; Esni F; Heeger K; Dengler J; Slater EP; Holler JPN; Baier A; Bartsch DK; Waldmann J
    Oncogene; 2018 Apr; 37(14):1845-1856. PubMed ID: 29367759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel monoclonal antibody directed at the receptor binding site on the avian sarcoma and leukosis virus Env complex.
    Ochsenbauer-Jambor C; Delos SE; Accavitti MA; White JM; Hunter E
    J Virol; 2002 Aug; 76(15):7518-27. PubMed ID: 12097564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RCAS/SCL-TVA animal model allows targeted delivery of polyoma middle T oncogene to vascular endothelial progenitors in vivo and results in hemangioma development.
    Sausville J; Molinolo AA; Cheng X; Frampton J; Takebe N; Gutkind JS; Feldman RA
    Clin Cancer Res; 2008 Jun; 14(12):3948-55. PubMed ID: 18559617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting retroviral vector infection to cells that express heregulin receptors using a TVA-heregulin bridge protein.
    Snitkovsky S; Young JA
    Virology; 2002 Jan; 292(1):150-5. PubMed ID: 11878917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.